World's Best Scientists 2026 revealed!
Ulf-Håkan Stenman

Ulf-Håkan Stenman

D-Index & Metrics

Medicine

D-Index
95
Citations
37239
World Ranking
9982
National Ranking
111

Overview

Ulf-Håkan Stenman is affiliated with the University of Helsinki in Finland and has focused primarily on the field of Medicine throughout their career. Their research encompasses a significant number of publications related to oncology, pulmonary and respiratory medicine, surgery, reproductive medicine, and molecular biology.

The scientist's subfields of study include:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Surgery
  • Reproductive Medicine
  • Molecular Biology

Topics frequently covered in their work are:

  • Peptidase Inhibition and Analysis
  • Pancreatic and Hepatic Oncology Research
  • Pancreatitis Pathology and Treatment
  • Prostate Cancer Treatment and Research
  • Hypothalamic control of reproductive hormones
  • Inflammatory Biomarkers in Disease Prognosis
  • Ovarian cancer diagnosis and treatment

Ulf-Håkan Stenman has collaborated regularly with co-authors including Hannu Koistinen, Caj Haglund, Kimmo Taari, And Demir, and Matti Hero.

The frequent publication venues for their work include:

  • Scientific Reports
  • Oncology
  • Cancers
  • Clinical Chemistry and Laboratory Medicine (CCLM)
  • IUBMB Life

Recent papers authored or co-authored by Ulf-Håkan Stenman include:

  • The roles of proteases in prostate cancer, 2023, IUBMB Life
  • Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma, 2021, Scientific Reports
  • Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products, 2021, ACS Chemical Biology
  • Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women, 2021, Pregnancy Hypertension
  • Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis, 2021, International Journal of Molecular Sciences

Best Publications

  • Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela

  • Prostate-Cancer Mortality at 11 Years of Follow-up

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

    Ulf-Hakan Stenman;Jari Leinonen;Henrik Alfthan;Sakari Rannikko

  • National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

    Catharine M. Sturgeon;Michael J. Duffy;Ulf Håkan Stenman;Hans Lilja

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Jonas Hugosson;Monique J. Roobol;Marianne Månsson;Teuvo L.J. Tammela

  • Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study

    Pär Stattin;Annika Bylund;Sabina Rinaldi;Carine Biessy

  • The role of SPINK1 in ETS rearrangement-negative prostate cancers.

    Scott A. Tomlins;Daniel R. Rhodes;Jianjun Yu;Sooryanarayana Varambally

  • Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene.

    K Aittomäki;R Herva;U H Stenman;K Juntunen

  • Human chorionic gonadotropin in cancer.

    Ulf-Håkan Stenman;Henrik Alfthan;Kristina Hotakainen

  • Tumor Necrosis Factor as a Potent Inhibitor of Adrenocorticotropin-Induced Cortisol Production and Steroidogenic P450 Enzyme Gene Expression in Cultured Human Fetal Adrenal Cells*

    Marja Jäättelä;Vesa Ilvesmäki;Raimo Voutilainen;Ulf-Håkan Stenman

  • A Nationwide Survey of Mortality in Acromegaly

    Ritva Kauppinen-Mäkelin;Timo Sane;Antti Reunanen;Matti J. Välimäki

  • Leptin is associated with increased prostate cancer risk : a nested case-referent study.

    Pär Stattin;Stefan Söderberg;Göran Hallmans;Annika Bylund

  • Prostate-specific antigen

    Ulf-Håkan Stenman;Jari Leinonen;Wan-Ming Zhang;Patrik Finne

  • Risk of Minor and Major Fetal Malformations in Diabetics with High Haemoglobin A1c Values in Early Pregnancy

    K. Ylinen;P. Aula;U. H. Stenman;T. Kesäniemi-Kuokkanen

  • CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.

    M Carpelan-Holmström;J Louhimo;U H Stenman;H Alfthan

  • Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy.

    Hannu Halila;Ulf‐Hǎkan Stenman;Markku Seppälä

  • Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

    Monique J. Roobol;Melissa Kerkhof;Fritz H. Schröder;Jack Cuzick

  • Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

    Eleftherios P Diamandis;Andreas Scorilas;Stefano Fracchioli;Marleen Van Gramberen

  • The classification, functions and clinical use of different isoforms of HCG

    Ulf-Håkan Stenman;Aila Tiitinen;Henrik Alfthan;Leena Valmu

  • Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants.

    Eero Kajantie;Leo Dunkel;Ursula Turpeinen;Ulf-Håkan Stenman

Frequent Co-Authors

Teuvo L.J. Tammela
Teuvo L.J. Tammela Tampere University
Anssi Auvinen
Anssi Auvinen Tampere University
Caj Haglund
Caj Haglund University of Helsinki
Markku Seppälä
Markku Seppälä Helsinki University Hospital
Hans Lilja
Hans Lilja Memorial Sloan Kettering Cancer Center
Matti Hakama
Matti Hakama Finnish Cancer Registry
Timo Sorsa
Timo Sorsa University of Helsinki
Tuula Salo
Tuula Salo University of Helsinki
Anders Bjartell
Anders Bjartell Lund University
Akseli Hemminki
Akseli Hemminki University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring alternative healthcare careers beyond medical school, there are a variety of flexible online options to consider. For those seeking a clinical path, online bsn programs for non nurses offer a streamlined route to becoming a registered nurse—ideal for individuals coming from non-nursing backgrounds.

Interested in administration or support roles? Pursuing a medical billing and coding online schools program can open the door to stable job opportunities in healthcare facilities, while offering the flexibility to study at your own pace.

If you want a faster entry into patient care, consider enrolling in an lpn program without teas test. These programs remove common testing barriers, making the journey to becoming a licensed practical nurse more accessible.

For those leaning toward leadership or managerial positions, earning an online healthcare management degree can prepare you for administrative roles in hospitals, clinics, and more. All of these pathways can be launched or advanced through online education, providing flexibility and a strong foundation for a rewarding healthcare career.

Best Scientists Citing Ulf-Håkan Stenman

Trending Scientists

Recently Published Articles